日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Flavonifractor plautii as a Next-Generation Probiotic Enhancing the NGP F/P Index in a Simulated Human Gut Microbiome Ecosystem

黄杆菌(Flavonifractor plautii)作为一种新一代益生菌,在模拟人类肠道微生物群生态系统中增强了NGP F/P指数。

Shuvo, Md Sarower Hossen; Kim, Sukyung; Jo, Sujin; Rahim, Md Abdur; Barman, Indrajeet; Hossain, Mohammed Solayman; Yoon, Youjin; Tajdozian, Hanieh; Ahmed, Izaz; Atashi, Ali; Jeong, GangWon; Suh, Ho-Seong; You, JiMin; Sung, Chaemin; Kim, Mijung; Seo, Hoonhee; Song, Ho-Yeon

Microbiome Therapeutic Lactiplantibacillus plantarum PMC105 for Systemic Carbapenem-Resistant Enterobacteriaceae Infections: Oral and Inhalation Efficacy In Vivo

微生物组疗法:植物乳杆菌 PMC105 用于治疗系统性耐碳青霉烯类肠杆菌感染:口服和吸入疗法的体内疗效

Sarafraz, Faezeh; Seo, Hoonhee; Tajdozian, Hanieh; Atashi, Ali; Yoon, Youjin; Kim, Sukyung; Song, Ho-Yeon

Microbiome therapeutic PMC101 inhibits the translocation of carbapenem-resistant Klebsiella while enhancing eubiosis in antibiotic-induced dysbiosis mice

微生物组治疗药物PMC101可抑制耐碳青霉烯类肺炎克雷伯菌的移位,同时增强抗生素诱导的菌群失调小鼠的菌群平衡。

Tajdozian, Hanieh; Seo, Hoonhee; Kim, Sukyung; Rahim, Md Abdur; Park, Hyun A; Sarafraz, Faezeh; Yoon, Youjin; Kim, Hokyoung; Barman, Indrajeet; Park, Chae-Eun; Ghorbanian, Fatemeh; Lee, Soyeon; Jeong, Hwal Rim; Song, Ho-Yeon

Clinical Potential of Novel Microbial Therapeutic LP51 Based on Xerosis-Microbiome Index.

基于干燥症-微生物组指数的新型微生物疗法LP51的临床潜力

Kim Sukyung, Rahim Md Abdur, Tajdozian Hanieh, Barman Indrajeet, Park Hyun-A, Yoon Youjin, Jo Sujin, Lee Soyeon, Shuvo Md Sarower Hossen, Bae Sung Hae, Lee Hyunji, Ju Sehee, Park Chae-Eun, Kim Ho-Kyoung, Han Jeung Hi, Kim Ji-Woong, Yoon Sung Geon, Kim Jae Hong, Choi Yang Gyu, Lee Saebim, Seo Hoonhee, Song Ho-Yeon